Skip to content
healthcare.dev

TOFACITINIB

NDC 76333-111, TOFACITINIB, tablet, film coated, extended release, from Orient Pharma Co., Ltd. Yunlin Plant.

Product NDC
76333-111
Status
Listed
Labeler
Orient Pharma Co., Ltd. Yunlin Plant
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA219830
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76333-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TOFACITINIB CITRATE11 mg/1

Pharmacologic classes

Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]

Package NDCNDC-11Package
76333-111-157633301111530 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (76333-111-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5617a652-a78e-74b1-e063-6394a90a31c7

Use it

Look up 76333-111 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76333-111 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76333-111. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.